LobbyingEncompass Health lobbying by quarter
Encompass Health's latest lobbying report covers Q2 2026, at $270K. The four quarters Q3 2025–Q2 2026 total $1.1M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Encompass Health
- Latest quarter
- $270K
- Q2 2026 · 1 reports
- Last 12 months
- $1.1M
- Last 4 quarters
- vs last quarter
- −20.6%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $290K | 1 |
| Q1 2023 | $300K | 1 |
| Q2 2023 | $280K | 1 |
| Q3 2023 | $32K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $220K | 1 |
| Q2 2024 | $250K | 1 |
| Q3 2024 | $410K | 1 |
| Q4 2024 | $360K | 1 |
| Q1 2025 | $300K | 1 |
| Q2 2025 | $220K | 1 |
| Q3 2025 | $280K | 1 |
| Q4 2025 | $230K | 1 |
| Q1 2026 | $340K | 1 |
| Q2 2026 | $270K | 1 |
Policy issues the reports name
- Health issues15 reports
- Medicare and Medicaid14 reports
A report that names several issues counts once for each.
Who was lobbied
- Centers For Medicare and Medicaid Services (CMS)15 reports
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseEncompass Health | $3.8M | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $270K |
| 04/20for Q1 | In-house | $340K |
| 01/20for Q4 2025 | In-house | $230K |
| 01/20for Q3 2025 | In-house | $280K |
| 01/20for Q4 2025 | In-house | $220K |
| 25/10/20for Q3 2025 | In-house | $220K |
| 25/07/23for Q1 2025 | In-house | $300K |
| 25/07/23for Q4 2024 | In-house | $360K |
| 25/07/21for Q2 2025 | In-house | $220K |
| 25/05/06for Q1 2025 | In-house | $230K |
| 25/01/23for Q3 2024 | In-house | $410K |
| 25/01/23for Q4 2024 | In-house | $315K |
| 24/11/05for Q3 2024 | In-house | $250K |
| 24/07/19for Q2 2024 | In-house | $250K |
| 24/04/24for Q1 2024 | In-house | $220K |
| 24/01/24for Q4 2023 | In-house | $10K |
| 24/01/02for Q4 2023 | In-house | $10K |
| 23/10/18for Q3 2023 | In-house | $32K |
| 23/07/20for Q2 2023 | In-house | $280K |
| 23/04/20for Q1 2023 | In-house | $300K |